Pharmaceutical Contract Manufacturing Market: Trends, Opportunities and Competitive Analysis [2024-2030]
Get it in 2 to 4 weeks by ordering today
Pharmaceutical Contract Manufacturing Market Trends and Forecast
The future of the global pharmaceutical contract manufacturing market looks promising with opportunities in the big pharmaceutical, small & medium-sized pharmaceutical, and generic pharmaceutical markets. The global pharmaceutical contract manufacturing market is expected t%li%reach an estimated $298.4 billion by 2030 with a CAGR of 7.9% from 2024 t%li%2030. The major drivers for this market are growing demand for generic and specialty medicines, increasing investments in pharmaceutical R&D activities, and rising trend for CMOs (contract manufacturing organization) for "one-stop-shop" benefit.
A more than 150-page report is developed t%li%help in your business decisions. Sample figures with some insights are shown below.
Pharmaceutical Contract Manufacturing Market by Segment
The study includes a forecast for the global pharmaceutical contract manufacturing market by services, end use industry, and region, as follows:
Pharmaceutical Contract Manufacturing Market by Services [Value ($B) Shipment Analysis from 2018 t%li%2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pharmaceutical contract manufacturing companies cater t%li%increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pharmaceutical contract manufacturing companies profiled in this report include.
Q1. What is the pharmaceutical contract manufacturing market size?
Answer: The global pharmaceutical contract manufacturing market is expected t%li%reach an estimated $298.4 billion by 2030.
Q2. What is the growth forecast for pharmaceutical contract manufacturing market?
Answer: The global pharmaceutical contract manufacturing market is expected t%li%grow with a CAGR of 7.9% from 2024 t%li%2030.
Q3. What are the major drivers influencing the growth of the pharmaceutical contract manufacturing market?
Answer: The major drivers for this market are growing demand for generic and specialty medicines, increasing investments in pharmaceutical R&D activities, and rising trend for CMOs (contract manufacturing organization) for "one-stop-shop" benefit.
Q4. What are the major segments for pharmaceutical contract manufacturing market?
Answer: The future of the pharmaceutical contract manufacturing market looks promising with opportunities in the big pharmaceutical, small & medium-sized pharmaceutical, and generic pharmaceutical markets.
Q5. Wh%li%are the key pharmaceutical contract manufacturing companies?
Answer: Some of the key pharmaceutical contract manufacturing companies are as follows:
Answer:Lucintel forecasts that biologics manufacturing will remain the largest segment over the forecast period due t%li%increasing need for producing vaccines and biosimilars.
Q7. In pharmaceutical contract manufacturing market, which region is expected t%li%be the largest in next 5 years?
Answer: APAC is expected t%li%remain the largest region due t%li%increasing demand from geriatric population, growing outsourcing activities and expansion of manufacturing capabilities of the local key players in the region.
Q8. D%li%we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the pharmaceutical contract manufacturing market by services (manufacturing [API, FDF (parenteral, injectable, tablet, capsule, and oral liquid)], drug development, and biologics manufacturing), end use industry (big pharmaceutical, small & medium-sized pharmaceutical, and generic pharmaceutical), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Wh%li%are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat d%li%they pose for loss of market share by material or product substitution?
Q.11. What M&A activity did occur in the last five years and how did they impact the industry?
For any questions related t%li%pharmaceutical contract manufacturing market or related t%li%pharmaceutical contract manufacturing companies, pharmaceutical contract manufacturing market size, pharmaceutical contract manufacturing market share, pharmaceutical contract manufacturing analysis, pharmaceutical contract manufacturing market growth, pharmaceutical contract manufacturing market research, write Lucintel analyst at email: [email protected] we will be glad t%li%get back t%li%you soon.
Pharmaceutical Contract Manufacturing Market Trends and Forecast
The future of the global pharmaceutical contract manufacturing market looks promising with opportunities in the big pharmaceutical, small & medium-sized pharmaceutical, and generic pharmaceutical markets. The global pharmaceutical contract manufacturing market is expected t%li%reach an estimated $298.4 billion by 2030 with a CAGR of 7.9% from 2024 t%li%2030. The major drivers for this market are growing demand for generic and specialty medicines, increasing investments in pharmaceutical R&D activities, and rising trend for CMOs (contract manufacturing organization) for "one-stop-shop" benefit.
A more than 150-page report is developed t%li%help in your business decisions. Sample figures with some insights are shown below.
Pharmaceutical Contract Manufacturing Market by Segment
The study includes a forecast for the global pharmaceutical contract manufacturing market by services, end use industry, and region, as follows:
Pharmaceutical Contract Manufacturing Market by Services [Value ($B) Shipment Analysis from 2018 t%li%2030]:
- Manufacturing
- API
- FDF (Parenteral, Injectable, Tablet, Capsule, and Oral Liquid)
- Drug Development
- Biologics Manufacturing
- Big Pharmaceutical
- Small & Medium-Sized Pharmaceutical
- Generic Pharmaceutical
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pharmaceutical contract manufacturing companies cater t%li%increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pharmaceutical contract manufacturing companies profiled in this report include.
- Therm%li%Fisher Scientific
- Catalent
- Lonza
- Almac Group
- Recipharm
- Patheon
- Grifols International
- Dalton Pharma Services
- AbbVie
- Lucintel forecasts that biologics manufacturing will remain the largest segment over the forecast period due t%li%increasing need for producing vaccines and biosimilars.
- Within this market, big pharmaceutical segment is expected t%li%remain the largest segment due t%li%growing trend among large pharmacies t%li%contract out pharmaceutical production in order t%li%minimize the pricing pressure and pipeline issues in their operations along with increasing demand for optimization of execution costs as bestselling medication patents expires.
- APAC is expected t%li%remain the largest region due t%li%increasing demand from geriatric population, growing outsourcing activities and expansion of manufacturing capabilities of the local key players in the region.
- Market Size Estimates: Pharmaceutical contract manufacturing market size estimation in terms of value ($B)
- Trend and Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments and regions.
- Segmentation Analysis: Pharmaceutical contract manufacturing market size by various segments, such as by services, end use industry, and region
- Regional Analysis: Pharmaceutical contract manufacturing market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different by services, end use industry, and regions for the pharmaceutical contract manufacturing market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape for the pharmaceutical contract manufacturing market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q1. What is the pharmaceutical contract manufacturing market size?
Answer: The global pharmaceutical contract manufacturing market is expected t%li%reach an estimated $298.4 billion by 2030.
Q2. What is the growth forecast for pharmaceutical contract manufacturing market?
Answer: The global pharmaceutical contract manufacturing market is expected t%li%grow with a CAGR of 7.9% from 2024 t%li%2030.
Q3. What are the major drivers influencing the growth of the pharmaceutical contract manufacturing market?
Answer: The major drivers for this market are growing demand for generic and specialty medicines, increasing investments in pharmaceutical R&D activities, and rising trend for CMOs (contract manufacturing organization) for "one-stop-shop" benefit.
Q4. What are the major segments for pharmaceutical contract manufacturing market?
Answer: The future of the pharmaceutical contract manufacturing market looks promising with opportunities in the big pharmaceutical, small & medium-sized pharmaceutical, and generic pharmaceutical markets.
Q5. Wh%li%are the key pharmaceutical contract manufacturing companies?
Answer: Some of the key pharmaceutical contract manufacturing companies are as follows:
- Therm%li%Fisher Scientific
- Catalent
- Lonza
- Almac Group
- Recipharm
- Patheon
- Grifols International
- Dalton Pharma Services
- AbbVie
Answer:Lucintel forecasts that biologics manufacturing will remain the largest segment over the forecast period due t%li%increasing need for producing vaccines and biosimilars.
Q7. In pharmaceutical contract manufacturing market, which region is expected t%li%be the largest in next 5 years?
Answer: APAC is expected t%li%remain the largest region due t%li%increasing demand from geriatric population, growing outsourcing activities and expansion of manufacturing capabilities of the local key players in the region.
Q8. D%li%we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the pharmaceutical contract manufacturing market by services (manufacturing [API, FDF (parenteral, injectable, tablet, capsule, and oral liquid)], drug development, and biologics manufacturing), end use industry (big pharmaceutical, small & medium-sized pharmaceutical, and generic pharmaceutical), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Wh%li%are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat d%li%they pose for loss of market share by material or product substitution?
Q.11. What M&A activity did occur in the last five years and how did they impact the industry?
For any questions related t%li%pharmaceutical contract manufacturing market or related t%li%pharmaceutical contract manufacturing companies, pharmaceutical contract manufacturing market size, pharmaceutical contract manufacturing market share, pharmaceutical contract manufacturing analysis, pharmaceutical contract manufacturing market growth, pharmaceutical contract manufacturing market research, write Lucintel analyst at email: [email protected] we will be glad t%li%get back t%li%you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1: Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2: Global Pharmaceutical Contract Manufacturing Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Pharmaceutical Contract Manufacturing Market by Services
3.3.1: Manufacturing
3.3.1.1: API
3.3.1.2: FDF (Parenteral, Injectable, Tablet, Capsule, and Oral Liquid)
3.3.2: Drug Development
3.3.3: Biologics Manufacturing
3.4: Global Pharmaceutical Contract Manufacturing Market by End Use Industry
3.4.1: Big Pharmaceutical
3.4.2: Small & Medium-Sized Pharmaceutical
3.4.3: Generic Pharmaceutical
3.4.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Pharmaceutical Contract Manufacturing Market by Region
4.2: North American Pharmaceutical Contract Manufacturing Market
4.2.1: North American Pharmaceutical Contract Manufacturing Market by Services: Manufacturing, Drug Development, and Biologics Manufacturing
4.2.2: North American Pharmaceutical Contract Manufacturing Market by End Use Industry: Big Pharmaceutical, Small & Medium-Sized Pharmaceutical, and Generic Pharmaceutical
4.3: European Pharmaceutical Contract Manufacturing Market
4.3.1: European Pharmaceutical Contract Manufacturing Market by Services: Manufacturing, Drug Development, and Biologics Manufacturing
4.3.2: European Pharmaceutical Contract Manufacturing Market by End Use Industry: Big Pharmaceutical, Small & Medium-Sized Pharmaceutical, and Generic Pharmaceutical
4.4: APAC Pharmaceutical Contract Manufacturing Market
4.4.1: APAC Pharmaceutical Contract Manufacturing Market by Services: Manufacturing, Drug Development, and Biologics Manufacturing
4.4.2: APAC Pharmaceutical Contract Manufacturing Market by End Use Industry: Big Pharmaceutical, Small & Medium-Sized Pharmaceutical, and Generic Pharmaceutical
4.5: ROW Pharmaceutical Contract Manufacturing Market
4.5.1: ROW Pharmaceutical Contract Manufacturing Market by Services: Manufacturing, Drug Development, and Biologics Manufacturing
4.5.2: ROW Pharmaceutical Contract Manufacturing Market by End Use Industry: Big Pharmaceutical, Small & Medium-Sized Pharmaceutical, and Generic Pharmaceutical
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Pharmaceutical Contract Manufacturing Market by Services
6.1.2: Growth Opportunities for the Global Pharmaceutical Contract Manufacturing Market by End Use Industry
6.1.3: Growth Opportunities for the Global Pharmaceutical Contract Manufacturing Market by Region
6.2: Emerging Trends in the Global Pharmaceutical Contract Manufacturing Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Pharmaceutical Contract Manufacturing Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pharmaceutical Contract Manufacturing Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Thermo Fisher Scientific
7.2: Catalent
7.3: Lonza
7.4: Almac Group
7.5: Recipharm
7.6: Patheon
7.7: Grifols International
7.8: Dalton Pharma Services
7.9: AbbVie
2. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1: Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2: Global Pharmaceutical Contract Manufacturing Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Pharmaceutical Contract Manufacturing Market by Services
3.3.1: Manufacturing
3.3.1.1: API
3.3.1.2: FDF (Parenteral, Injectable, Tablet, Capsule, and Oral Liquid)
3.3.2: Drug Development
3.3.3: Biologics Manufacturing
3.4: Global Pharmaceutical Contract Manufacturing Market by End Use Industry
3.4.1: Big Pharmaceutical
3.4.2: Small & Medium-Sized Pharmaceutical
3.4.3: Generic Pharmaceutical
3.4.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Pharmaceutical Contract Manufacturing Market by Region
4.2: North American Pharmaceutical Contract Manufacturing Market
4.2.1: North American Pharmaceutical Contract Manufacturing Market by Services: Manufacturing, Drug Development, and Biologics Manufacturing
4.2.2: North American Pharmaceutical Contract Manufacturing Market by End Use Industry: Big Pharmaceutical, Small & Medium-Sized Pharmaceutical, and Generic Pharmaceutical
4.3: European Pharmaceutical Contract Manufacturing Market
4.3.1: European Pharmaceutical Contract Manufacturing Market by Services: Manufacturing, Drug Development, and Biologics Manufacturing
4.3.2: European Pharmaceutical Contract Manufacturing Market by End Use Industry: Big Pharmaceutical, Small & Medium-Sized Pharmaceutical, and Generic Pharmaceutical
4.4: APAC Pharmaceutical Contract Manufacturing Market
4.4.1: APAC Pharmaceutical Contract Manufacturing Market by Services: Manufacturing, Drug Development, and Biologics Manufacturing
4.4.2: APAC Pharmaceutical Contract Manufacturing Market by End Use Industry: Big Pharmaceutical, Small & Medium-Sized Pharmaceutical, and Generic Pharmaceutical
4.5: ROW Pharmaceutical Contract Manufacturing Market
4.5.1: ROW Pharmaceutical Contract Manufacturing Market by Services: Manufacturing, Drug Development, and Biologics Manufacturing
4.5.2: ROW Pharmaceutical Contract Manufacturing Market by End Use Industry: Big Pharmaceutical, Small & Medium-Sized Pharmaceutical, and Generic Pharmaceutical
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Pharmaceutical Contract Manufacturing Market by Services
6.1.2: Growth Opportunities for the Global Pharmaceutical Contract Manufacturing Market by End Use Industry
6.1.3: Growth Opportunities for the Global Pharmaceutical Contract Manufacturing Market by Region
6.2: Emerging Trends in the Global Pharmaceutical Contract Manufacturing Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Pharmaceutical Contract Manufacturing Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pharmaceutical Contract Manufacturing Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Thermo Fisher Scientific
7.2: Catalent
7.3: Lonza
7.4: Almac Group
7.5: Recipharm
7.6: Patheon
7.7: Grifols International
7.8: Dalton Pharma Services
7.9: AbbVie
